Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Vaccine ; 29(2): 212-20, 2010 Dec 16.
Article in English | MEDLINE | ID: mdl-21050901

ABSTRACT

The emergence of Hendra Virus (HeV) and Nipah Virus (NiV) which can cause fatal infections in both animals and humans has triggered a search for an effective vaccine. Here, we have explored the potential for generating an effective humoral immune response to these zoonotic pathogens using an alphavirus-based vaccine platform. Groups of mice were immunized with Venezuelan equine encephalitis virus replicon particles (VRPs) encoding the attachment or fusion glycoproteins of either HeV or NiV. We demonstrate the induction of highly potent cross-reactive neutralizing antibodies to both viruses using this approach. Preliminary study suggested early enhancement in the antibody response with use of a modified version of VRP. Overall, these data suggest that the use of an alphavirus-derived vaccine platform might serve as a viable approach for the development of an effective vaccine against the henipaviruses.


Subject(s)
Antibodies, Neutralizing/blood , Antibodies, Viral/blood , Encephalitis Virus, Venezuelan Equine/genetics , Hendra Virus/immunology , Henipavirus Infections/prevention & control , Nipah Virus/immunology , Animals , Female , Gene Expression , Genetic Vectors , Hendra Virus/genetics , Henipavirus Infections/immunology , Mice , Mice, Inbred C3H , Nipah Virus/genetics , Vaccines, Synthetic/genetics , Vaccines, Synthetic/immunology , Viral Proteins/genetics , Viral Proteins/immunology
SELECTION OF CITATIONS
SEARCH DETAIL